Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kangenkaryu prevents the decrease of cholinergic markers following the nucleus basalis magnocellularis lesion.

M Takahashi1, K Sugaya, K Kubota

  • 1Research Institute for Biosciences, Science University of Tokyo, Chiba, Japan.

Japanese Journal of Pharmacology
|November 1, 1992
PubMed
Summary

Kangenkaryu (KAN), a traditional Chinese medicine, may protect brain cells in an Alzheimer's disease model. It helped preserve key markers of brain cell function after nucleus basalis magnocellularis (nbm) lesions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Positron emission tomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up cases of lung cancer.

Clinical nuclear medicine·1992
Same author

Possible mechanisms of action of the antispasmodic agent tiropramide in the isolated detrusor from rats.

Japanese journal of pharmacology·1992
Same author

Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1992
Same author

[Enhancement of the effects of anticancer agents on B16 melanoma cells by combination with cepharanthine--I. Alkaloids].

Gan to kagaku ryoho. Cancer & chemotherapy·1992
Same author

[Enhancement of the effects of anticancer agents on B16 melanoma cells by combination with cepharanthine--II. Antimetabolite, alkylating agent, nitrosourea].

Gan to kagaku ryoho. Cancer & chemotherapy·1992
Same author

Tachycardia during cisapride treatment.

BMJ (Clinical research ed.)·1992

Area of Science:

  • Neuroscience
  • Pharmacology
  • Traditional Chinese Medicine

Background:

  • The nucleus basalis magnocellularis (nbm)-lesioned rat serves as an animal model for Alzheimer's disease (AD)-related cholinergic dysfunction.
  • Cholinergic markers, including acetylcholine release and choline acetyltransferase activity, are notably reduced in the cerebral cortex following nbm lesions.

Purpose of the Study:

  • To investigate the potential neuroprotective effects of Kangenkaryu (KAN), a traditional Chinese medicine, on cholinergic neurons.
  • To evaluate KAN's efficacy in preserving cholinergic markers in an nbm-lesion rat model.

Main Methods:

  • Induction of nucleus basalis magnocellularis (nbm) lesions in rats.
  • Oral administration of Kangenkaryu (KAN) post-lesion.
  • Measurement of cholinergic markers (acetylcholine release and choline acetyltransferase activity) in the cerebral cortex.

Related Experiment Videos

Main Results:

  • nbm-lesioned rats exhibited decreased cholinergic markers in the cerebral cortex.
  • Oral administration of KAN significantly preserved acetylcholine release and choline acetyltransferase activity in the lesioned rats.
  • KAN treatment mitigated the reduction of key cholinergic markers post-nbm lesion.

Conclusions:

  • Kangenkaryu (KAN) demonstrates a protective effect on cholinergic neurons in the cerebral cortex following nbm lesions.
  • The findings suggest KAN may be a potential therapeutic agent for conditions involving cholinergic deficits, such as Alzheimer's disease.